{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:23:03Z","timestamp":1762917783283,"version":"3.40.5"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research on rare and intractable diseases"},{"name":"Health and Labour Sciences Research"},{"name":"JSPS KAKENHI","award":["26860678"],"award-info":[{"award-number":["26860678"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.parkreldis.2017.06.003","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T19:36:42Z","timestamp":1497296202000},"page":"85-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Reduced orexin immunoreactivity in Perry syndrome and multiple system atrophy"],"prefix":"10.1016","volume":"42","author":[{"given":"Takayasu","family":"Mishima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kasanuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Castanedes-Casey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew K.","family":"Wszolek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-7917","authenticated-orcid":false,"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.parkreldis.2017.06.003_bib1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.parkreldis.2014.05.004","article-title":"Three families with Perry syndrome from distinct parts of the world","volume":"20","author":"Tacik","year":"2014","journal-title":"Park. Relat. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2017.06.003_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.parkreldis.2008.07.005","article-title":"Pallidonigral TDP-43 pathology in Perry syndrome","volume":"15","author":"Wider","year":"2009","journal-title":"Park. Relat. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2017.06.003_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.parkreldis.2010.07.001","article-title":"Autonomic failures in Perry syndrome with DCTN1 mutation","volume":"16","author":"Ohshima","year":"2010","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2017.06.003_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.parkreldis.2016.04.025","article-title":"DCTN1\u00a0p.K56R in progressive supranuclear palsy","volume":"28","author":"Gustavsson","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2017.06.003_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00401-007-0246-1","article-title":"Neurodegeneration involving putative respiratory neurons in Perry syndrome","volume":"115","author":"Tsuboi","year":"2008","journal-title":"Acta neuropathol."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.06.003_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1748-1716.2009.02036.x","article-title":"Activation of the basal forebrain by the orexin\/hypocretin neurones","volume":"198","author":"Arrigoni","year":"2010","journal-title":"Acta Physiol. (Oxf)"},{"key":"10.1016\/j.parkreldis.2017.06.003_bib7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2014.03.020","article-title":"Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies","volume":"569","author":"Kasanuki","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.06.003_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-006-0150-0","article-title":"Involvement of hypocretin neurons in multiple system atrophy","volume":"113","author":"Benarroch","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.parkreldis.2017.06.003_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/ana.22340","article-title":"Anatomy of disturbed sleep in pallido-ponto-nigral degeneration","volume":"69","author":"Spector","year":"2011","journal-title":"Ann. Neurol."},{"issue":"Pt 12","key":"10.1016\/j.parkreldis.2017.06.003_bib10","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/brain\/awh303","article-title":"The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations","volume":"127","author":"Ozawa","year":"2004","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.parkreldis.2017.06.003_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.parkreldis.2007.08.012","article-title":"CSF hypocretin-1 levels are normal in multiple-system atrophy","volume":"14","author":"Abdo","year":"2008","journal-title":"Park. Relat. Disord."},{"issue":"12","key":"10.1016\/j.parkreldis.2017.06.003_bib12","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/mds.21668","article-title":"Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy","volume":"22","author":"Martinez-Rodriguez","year":"2007","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"issue":"2","key":"10.1016\/j.parkreldis.2017.06.003_bib13","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0014-4886(03)00388-1","article-title":"Relationship between CSF hypocretin levels and hypocretin neuronal loss","volume":"184","author":"Gerashchenko","year":"2003","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.06.003_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1152\/japplphysiol.00679.2006","article-title":"Vigilance state-dependent attenuation of hypercapnic chemoreflex and exaggerated sleep apnea in orexin knockout mice","volume":"102","author":"Nakamura","year":"2007","journal-title":"J.\u00a0Appl. Physiol."},{"issue":"12","key":"10.1016\/j.parkreldis.2017.06.003_bib15","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.5665\/sleep.6304","article-title":"Arousal intensity is a distinct pathophysiological trait in obstructive sleep apnea","volume":"39","author":"Amatoury","year":"2016","journal-title":"Sleep"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017302109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802017302109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T19:20:44Z","timestamp":1535743244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802017302109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":15,"alternative-id":["S1353802017302109"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.06.003","relation":{},"ISSN":["1353-8020"],"issn-type":[{"type":"print","value":"1353-8020"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduced orexin immunoreactivity in Perry syndrome and multiple system atrophy","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}